News | News By Subject | News by Disease News By Date | Search News

Coronary artery bypass graft News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Medicure Inc. (MCU) Mulling Early Data Release for Heart Drug Two Months Ahead of Schedule     9/20/2007
Alchemia Release: Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS)     10/4/2006
FDA Issues Public Health Advisory For Bayer AG (BAY)'s Trasylol; Drug Linked To Higher Risks Of Serious Side Effects     2/8/2006
Alexion Pharmaceuticals Inc. (ALXN) Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations     11/23/2005
Medtronic, Inc. (MDT) Stent Misses Target     10/17/2005
Boston Scientific Corporation (BSX) To Pay Israeli Company Medinol Ltd. $750 Million     9/22/2005
Corgentech, Inc. (CGTK) Reduces Expenses And Focuses Development Efforts; Slashes Workforce By 45 Percent     4/20/2005
Corgentech, Inc. (CGTK) And Bristol-Myers Squibb Company (BMY) Announce Results From Edifoligide (E2F Decoy) Phase 3 Trial For Coronary Artery Bypass Graft Failure; Failed To Meet The Trial's Primary And Secondary Endpoints     3/30/2005
Corgentech, Inc. (CGTK) Plans Meeting With FDA To Discuss Registration Strategy Prior To Unblinding Of Phase 3 Trial     2/24/2005
TyRx Pharma Inc. Announces Equity Investment By Boston Scientific Corporation (BSX)     2/1/2005
Abbott Laboratories (ABT) Announces Groundbreaking New Trial In Stroke Prevention     1/18/2005
Millennium Pharmaceuticals (Massachusetts) (MLNM) And XOMA (XOMA) Announce Restructuring Of Collaboration Agreement For The Development Of MLN2222     10/12/2004

News from Around the Web

Press Releases
Allon Therapeutics, Inc. Releases Phase II MCI-CABG Results     8/29/2008
Allon Therapeutics, Inc. Completes Dosing in Phase II Cognitive Impairment Trial     5/23/2008
Bayer HealthCare Pharmaceuticals (BAY) Issues Additional Guidance to Physicians on Trasylol(R)     10/25/2007
Stentys to Report Acute Results of Preclinical Testing With Its Bifurcated Stent     5/15/2007
Medicure Inc. (MCU) Announces Successful DSMB Review for the Phase 3 MEND-CABG II Trial     5/7/2007
The Medicines Company (MDCO) Products Angiomax(R) (bivalirudin) and Cleviprex(TM) (clevidipine) Featured in Three Late Breaking Trials at American College of Cardiology Annual Scientific Session     3/15/2007
Allon Therapeutics, Inc. Confirms Progress In AL-208 Phase II Clinical Trial     1/22/2007
AVI BioPharma, Inc. (AVII) Initiates NEUGENE Antisense Clinical Program In Coronary Artery Bypass Grafting     10/18/2006
GlaxoSmithKline (GSK) Release: FDA Grants Priority Review For ARIXTRA(R) (fondaparinux sodium) In The Treatment Of Acute Coronary Syndromes     10/2/2006
diaDexus Release: New Data Published In An American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds To The Diagnostic Accuracy Of Traditional Risk Assessment For Future Cardiovascular Events     6/26/2006
Tryton Medical, Inc. Announces First Clinical Use Of Its Side-Branch Stent (TM) To Treat Coronary Bifurcation Lesions     5/15/2006
Conor Medsystems, Inc. Initiates RAPID Clinical Study For First Pimecrolimus Drug-Eluting Stent     5/11/2006
Boston Scientific Corporation (BSX) To Release Latest Clinical Trial Results On Market-Leading TAXUS(R) Coronary Stent Systems At EuroPCR     5/10/2006
Neuren Pharmaceuticals Limited Release: Brain Protectant Drug Successfully Completes Safety Trial     4/27/2006
Inspire Pharmaceuticals (ISPH) Announces Initiation Of Phase 2 Clinical Trial Of Platelet Aggregation Inhibitor     4/26/2006

//-->